期刊
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
卷 17, 期 14, 页码 2180-2186出版社
IVYSPRING INT PUBL
DOI: 10.7150/ijms.48456
关键词
Age-related disease; Hypertension; ET-1; Telomerase; Telomere
资金
- Shandong Provincial Natural Science Foundation, China [2016ZDJS07A09, ZR201702160271]
- Key R&D projects of Shandong Province, China [2017GSF201065]
- Natural Science Foundation of China [31571421]
- Swedish Cancer Society
- Swedish Research Council
- Cancer Society in Stockholm
- Karolinska Institutet Foundation
Background: The essential hypertension (EH) pathophysiology remains poorly understood. Many studies indicate that reduced leukocyte telomere length (LTL) is involved in the EH pathogenesis, however, the direct analysis of arterial telomere length (ATL) from EH patients and normotensive individuals did not show a difference. To address these discrepant observations between LTL and ATL, we performed comprehensive analyses of LTL, telomerase gene expression and their genetic variants in healthy normotensive controls and EH patients. Methods: Sex-matched 206 EH patients and equal numbers of healthy controls were recruited. LTL, and the expression of two key telomerase components, telomerase reverse transcriptase (TERT) and internal RNA template (TERC) were determined using qPCR. Genetic variants of rs2736100 at the TERT and rs12696304 at the TERC loci were determined using TaqMan genotyping kits. Results: LTL was significantly shorter in EH patients than in their normotensive controls (0.96 +/- 0.52 vs 1.19 +/- 0.58, P = 0.001). Moreover, TERT and TERC expression in patients' leukocytes were substantially lower compare to that in healthy controls (TERT, 0.98 +/- 0.98 vs 1.76 +/- 1.75, P = 0.003; TERC, 1.26 +/- 1.62 vs 4.69 +/- 3.61, P < 0.001). However, there were no differences in the genetic variants of rs2736100 and rs12696304 between patient and control groups. Conclusions: EH patients have significantly shorter LTL, which may result from defective TERT and TERC expression in leukocytes. Collectively, lower telomerase expression contributes to shorter LTL observed in EH patients, and telomerase activators may be considered for EH therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据